XML 88 R77.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Acquisitions - Summary of Information on Acquisitions to Company's Financial Statements (Details) - USD ($) $ in Millions | 12 Months Ended |
--- | --- | ---
Dec. 31, 2024 | Dec. 31, 2023 | May 06, 2024
Business Acquisition [Line Items] |  |  |  |
Initial cash consideration |  | $ 1,648.8 | $ 242.6 |
Business/technology acquired |  | $ 307.5 | $ 119.5 |
Nanostring Technologies |  |  |  |
Business Acquisition [Line Items] |  |  |  |
Acquisition date |  | May 06, 2024 |  |
Initial cash consideration |  | $ 392.6 |  |
Acquired interest |  | 100.00% |  |
Business/technology acquired |  | $ 90.8 |  | $ 44.7
ELITechGroup |  |  |  |
Business Acquisition [Line Items] |  |  |  |
Acquisition date |  | Apr. 30, 2024 |  |
Initial cash consideration |  | $ 951.9 |  |
Acquired interest |  | 100.00% |  |
Business/technology acquired |  | $ 66.9 |  |
Chemspeed Technologies A G |  |  |  |
Business Acquisition [Line Items] |  |  |  |
Acquisition date |  | Mar. 06, 2024 |  |
Initial cash consideration |  | $ 175.4 |  |
Acquired interest |  | 100.00% |  |
Business/technology acquired |  | $ 106.7 |  |
Spectral Instruments Imaging LLC |  |  |  |
Business Acquisition [Line Items] |  |  |  |
Acquired interest |  | 100.00% |  |
Additional consideration 1 |  | $ 10.0 |  |
Additional consideration |  | $ 10.0 |  |
Nion, LLC |  |  |  |
Business Acquisition [Line Items] |  |  |  |
Acquired interest |  | 100.00% |  |
Additional consideration 1 |  | $ 23.0 |  |
Additional consideration |  | $ 23.0 |  |
Biognosys, AG |  |  |  |
Business Acquisition [Line Items] |  |  |  |
Acquisition date |  |  | Jan. 03, 2023 |
Initial cash consideration |  |  | $ 73.6 |
Acquired interest |  |  | 97.15% |
Remaining ownership percentage under options that can be exercised after acquisition period |  |  | 2.85% |
Business/technology acquired |  |  | $ 25.4 |
PhenomeX Inc [Member] |  |  |  |
Business Acquisition [Line Items] |  |  |  |
Acquisition date |  |  | Oct. 02, 2023 |
Initial cash consideration | [1] |  | $ 121.2 |
Acquired interest |  |  | 100.00% |
Business/technology acquired |  |  | $ 74.3 |
[1] | Total cash consideration consisted of $107.2 million for the acquisition of the outstanding stock including an $8.0 million payment to settle an employee award, and settlement of a $14.0 million note previously issued by the Company to PhenomeX during 2023. (b) This amount includes an assumed liability for vested employee awards of $6.3 million on the acquisition date which was settled in the post-closing period ended March 31, 2023, for Biognosys, AG.

X
- Definition The percentage of shares remaining that were included in the options provided to the non-controlling shareholders. + References No definition available. + Details
Name: | brkr_VotingEquityInterestIncludedInOptionsProvidedToShareholdersPercentage
Namespace Prefix: | brkr_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Date when the business acquisition agreement was executed, in YYYY-MM-DD format. + References No definition available. + Details
Name: | us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 805 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479907/805-20-50-5 + Details
Name: | us-gaap_BusinessAcquisitionLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of voting equity interests acquired at the acquisition date in the business combination. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2 + Details
Name: | us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (c)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1 + Details
Name: | us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of liabilities assumed at the acquisition date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1 + Details
Name: | us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 805 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13 + Details
Name: | us-gaap_PaymentsToAcquireBusinessesGross
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=brkr_NanostringTechnologiesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=brkr_ElitechgroupMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=brkr_ChemspeedTechnologiesAGMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=brkr_SpectralInstrumentsImagingLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=brkr_NionLlcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=brkr_BiognosysAgMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=brkr_PhenomexIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |